Camptothecin suppresses NRF2-ARE activity and sensitises hepatocellular carcinoma cells to anticancer drugs. [electronic resource]
Producer: 20171113Description: 1495-1506 p. digitalISSN:- 1532-1827
- Adult
- Aged
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Camptothecin -- pharmacology
- Carboxylic Ester Hydrolases -- metabolism
- Carcinoma, Hepatocellular -- drug therapy
- Drug Resistance, Neoplasm -- drug effects
- Female
- Humans
- Liver Neoplasms -- drug therapy
- Male
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Middle Aged
- NF-E2-Related Factor 2 -- biosynthesis
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.